1. 340 Phase 1 study of AMG 160, a half-life extended BiTE® (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer. (10th December 2020) Authors: Dorff, Tanya; Rettig, Matthew; Machiels, Jean-Pascal; Lolkema, Martijn; Autio, Karen; Greil, Richard; Rottey, Sylvie; Adra, Nabil; Salvati, Mark; Poon, Shirley; Tan, Daniel; Jurida, Gabor; Kouros-Mehr, Hosein; Fizazi, Karim; Tran, Ben; Horvath, Lisa Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of long‐term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab‐refractory chronic lymphocytic leukaemia with deletion 17p. (14th February 2013) Authors: Namberger, Konrad; Weiss, Lukas; Krause, Barbara; Melchardt, Thomas; Greil, Richard Journal: European journal of haematology Issue: Volume 90:Number 4(2013:Apr.) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A modified scoring of the NCCN‐IPI is more accurate in the elderly and is improved by albumin and β2‐microglobulin. (19th September 2014) Authors: Melchardt, Thomas; Troppan, Katharina; Weiss, Lukas; Hufnagl, Clemens; Neureiter, Daniel; Tränkenschuh, Wolfgang; Hopfinger, Georg; Magnes, Teresa; Deutsch, Alexander; Neumeister, Peter; Hackl, Hubert; Greil, Richard; Pichler, Martin; Egle, Alexander Journal: British journal of haematology Issue: Volume 168:Number 2(2015:Jan.) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1. Issue 5 (19th August 2020) Authors: Heibl, Sonja; Buxhofer‐Ausch, Veronika; Schmidt, Stefan; Webersinke, Gerald; Lion, Thomas; Piringer, Gudrun; Kuehr, Thomas; Wolf, Dominik; Melchardt, Thomas; Greil, Richard; Thaler, Josef Journal: Hematological oncology Issue: Volume 38:Issue 5(2020) Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Issue 5 (4th May 2018) Authors: Burgstaller, Sonja; Stauder, Reinhard; Kuehr, Thomas; Lang, Alois; Machherndl-Spandl, Sigrid; Mayrbaeurl, Beate; Noesslinger, Thomas; Petzer, Andreas; Valent, Peter; Greil, Richard; Thaler, Josef Journal: Leukemia & lymphoma Issue: Volume 59:Issue 5(2018) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study. (15th June 2016) Authors: Leierer, Gisela; Grabmeier-Pfistershammer, Katharina; Steuer, Andrea; Sarcletti, Mario; Geit, Maria; Haas, Bernhard; Taylor, Ninon; Kanatschnig, Manfred; Rappold, Michaela; Ledergerber, Bruno; Zangerle, Robert; Egle, Alexander; Geit, Maria; Haas, Bernhard; Kanatschnig, Manfred; Rieger, Armin; Ste... Journal: Open forum infectious diseases Issue: Volume 3:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. (January 2022) Authors: Diallo, Alpha; Trøseid, Marius; Simensen, Victoria Charlotte; Boston, Anaïs; Demotes, Jacques; Olsen, Inge Christoffer; Chung, Florence; Paiva, José Artur; Hites, Maya; Ader, Florence; Arribas, Jose Ramon; Baratt-Due, Andreas; Melien, Øyvind; Tacconelli, Evelina; Staub, Thèrèse; Greil, Richard; T... Journal: Clinical microbiology and infection Issue: Volume 28:Number 1(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adipocyte-derived players in hematologic tumors: useful novel targets?. (January 2015) Authors: Jöhrer, Karin; Ploner, Christian; Thangavadivel, Shanmugapriya; Wuggenig, Philipp; Greil, Richard Journal: Expert opinion on biological therapy Issue: Volume 15:Number 1(2015:Jan.) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9992 (1st August 2015) Authors: Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C; Hubalek, Michael; Greil, Richard; Jakesz, Raimund; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger, Elisabeth; Bjelic-Radisic, Vesna; Artner-Matuschek, Silvia; Fitzal, Florian; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; S... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9992 (1st August 2015) Authors: Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C; Hubalek, Michael; Greil, Richard; Jakesz, Raimund; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger, Elisabeth; Bjelic-Radisic, Vesna; Artner-Matuschek, Silvia; Fitzal, Florian; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; S... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗